Jaridon 6 exerts its effects by inhibiting SIRT1 activity, further affecting the (Phosphatidylinositol 3-Kinase)PI3K/AKT signaling pathway, inducing autophagy, and promoting the death of drug-resistant cancer cells (Fu et al., 2021). Here, SIRT1 is linked to cancer.